Bioactivity Comments |
ALM201 enhances FKBPL antiangiogenic activity. |
Targets where the ligand is described in the comment field | |
Target | Comment |
FKBP prolyl isomerase like | Peptides based on the non-functional PPIase domain of FKBPL (e.g. AD-01 and ALM201) have potent anti-tumour activity by inhibiting angiogenesis and promoting the differentiation of cancer stem cells [2-5]. |